Buscar
Mostrando ítems 1-10 de 970
From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
The global pandemic of COVID-19 caused by SARS-CoV-2 (also known as 2019-nCoV and HCoV-19) has
posed serious threats to public health and economic stability worldwide, thus calling for development of
vaccines against ...
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses
The extensive efforts around the globe are being made to develop a suitable vaccine against COVID-19
(Coronavirus Disease-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). An effective vaccine ...
Approaches and challenges in SARS-CoV-2 vaccine development
The explosive spread of SARS-CoV-2 suggests that a vaccine will be required to end this global pandemic.
Progress in SARS-CoV-2 vaccine development to date has been faster than for any other pathogen in history.
Multiple ...
Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
Coronaviruses (CoVs) are a large family of viruses that cause illness
ranging from the common cold to more severe diseases such as Severe Acute
Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS).
Severe ...
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant
concern to public health care worldwide. As of August 19, 2020, more than 22,140,472 people
are infected, and over 781,135 people have died ...
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
The development of a massively producible vaccine against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential
for stopping the current coronavirus disease (COVID-19) pandemic. ...
SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
The development of a massively producible vaccine against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential
for stopping the current coronavirus disease (COVID-19) pandemic. ...
Could BCG vaccination induce protective trained immunity for SARS-CoV-2?
(2020)
Trained immunity is a type of non-specific memory-like immune response induced by some pathogens and vaccines, such as BCG, which can confer antigen-independent protection against a wide variety of pathogens. The BCG vaccine ...